Radiopharm Theranostics (ASX:RAD) Price-to-Tangible-Book : (As of Jun. 19, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Radiopharm Theranostics Price-to-Tangible-Book?

As of today (2024-06-19), Radiopharm Theranostics's share price is A$0.034. Radiopharm Theranostics's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was A$-0.09. Hence, Radiopharm Theranostics's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Radiopharm Theranostics's Price-to-Tangible-Book or its related term are showing as below:

During the past 2 years, Radiopharm Theranostics's highest Price to Tangible Book Ratio was 6.67. The lowest was 5.00. And the median was 6.00.

ASX:RAD's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.65
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Radiopharm Theranostics's share price is A$0.034. Radiopharm Theranostics's Book Value per Sharefor the quarter that ended in Dec. 2023 was A$0.07. Hence, Radiopharm Theranostics's P/B Ratio of today is 0.52.

Radiopharm Theranostics Price-to-Tangible-Book Historical Data

The historical data trend for Radiopharm Theranostics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radiopharm Theranostics Price-to-Tangible-Book Chart

Radiopharm Theranostics Annual Data

Trend

Jun22

Jun23

Price-to-Tangible-Book

6.00

Radiopharm Theranostics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	6.67	6.00	5.00	-	-

Competitive Comparison of Radiopharm Theranostics's Price-to-Tangible-Book

For the Biotechnology subindustry, Radiopharm Theranostics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Radiopharm Theranostics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Radiopharm Theranostics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Radiopharm Theranostics's Price-to-Tangible-Book falls into.

Radiopharm Theranostics Price-to-Tangible-Book Calculation

Radiopharm Theranostics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.034	/	-0.087
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Radiopharm Theranostics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Radiopharm Theranostics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Radiopharm Theranostics (ASX:RAD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Radiopharm Theranostics Ltd (ASX:RAD) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

RDPTF:USA

Address

62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053

Website

https://www.radiopharmtheranostics.com

Radiopharm Theranostics Ltd is a Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialisation of health technologies.

Radiopharm Theranostics (ASX:RAD) Headlines

No Headlines